Fulgent Genetics (FLGT) Share-based Compensation (2016 - 2026)

Fulgent Genetics (FLGT) has 11 years of Share-based Compensation data on file, last reported at $9.9 million in Q1 2026.

• Quarterly Share-based Compensation fell 6.26% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.9 million (down 10.55% YoY) and the FY2025 annual result came in at $39.6 million, down 11.01% from the prior year.
• Share-based Compensation grew to $9.9 million in Q1 2026 per FLGT's latest filing, from $9.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $11.6 million in Q2 2024, with the low at $5.6 million in Q1 2022.
• Average Share-based Compensation over 5 years is $10.0 million, with a median of $10.3 million recorded in 2023.
• Year-over-year, Share-based Compensation jumped 127.74% in 2022 and slipped 13.72% in 2025.
• Fulgent Genetics' Share-based Compensation stood at $10.0 million in 2022, then climbed by 14.07% to $11.4 million in 2023, then declined by 8.96% to $10.4 million in 2024, then declined by 10.88% to $9.3 million in 2025, then climbed by 6.62% to $9.9 million in 2026.
• Business Quant data shows FLGT's Share-based Compensation at $9.9 million in Q1 2026, $9.3 million in Q4 2025, and $9.7 million in Q3 2025.